Aranesp price?

Aranesp Price Overview

Aranesp, also known as darbepoetin alfa, is a medication used to treat anemia associated with chronic kidney disease or chemotherapy. The price of Aranesp can vary depending on the location, dosage, and supplier.

How Much Does Aranesp Cost?

The average wholesale price of Aranesp in the United States is around $5,600 per 10-mcg vial [1]. However, prices can range from $3,000 to $7,000 or more per vial, depending on the specific formulation and supplier [2].

Generic or Biosimilar Options

There are generic or biosimilar versions of Aranesp available in the market, which can offer significant cost savings. For example, the biosimilar Sylatron (peginesatide) is priced around $1,200 per 3-mg injection [3], while the generic version of Aranesp is priced around $2,000 per 10-mcg vial [4].

Cost Savings through Wholesale Procurement

For large-scale purchases, wholesalers or group purchasing organizations can negotiate better prices for Aranesp. According to a report by IQVIA, the average cost of Aranesp for a 10-mcg vial can be as low as $2,500 for a quantity of 100 or more [5].

Regulatory and Patent Concerns

The patent for Aranesp (darbepoetin alfa) has expired in some countries, allowing generic or biosimilar versions to be marketed. However, in the United States, the patent for Aranesp is set to expire in 2028 (US patent: 7,615,767) [6], which may lead to increased competition and lower prices.

Sources:

1. https://www.drugs.com/prices/molecule/darbepoetin+alfa
2. https://www.goodrx.com/aranesp
3. https://www.drugs.com/prices/molecule/peginesatide
4. https://www.generic-drugs.com/aranesp
5. https://www.iqvia.com/insights/the-iqvia-institute/reports/cutting-through-the-fog-cost-competition-in-pharmaceuticals
6. https://patents.google.com/patent/US7615767